Lymphoma and Bendamustine with Dr Pierre Laneuville

Описание: Dr. Pierre Laneuville is an Associate Professor (GFT-U) in the Department of Medicine and Oncology at McGill University and the former Head of Hematology for the McGill University Health Center talks about the treatment of lymphoma using Bendamustine.

Dr. Laneuville obtained an Honours B.Sc. at McMaster University, his medical degree at the University of Ottawa, trained in internal Medicine at McGill University, and completed his hematology sub-specialty and research training with Dr. B.A. Cooper at the Royal Victoria Hospital and McGill University from 1985 to 1989. He then joined the staff and faculty at the Royal Victoria Hospital and McGill University and has focused his clinical and laboratory research activities on hematological malignancies.

Dr. Laneuville is best known for his research on the molecular mechanisms underlying the genesis and transformation of chronic myelogenous leukemia. He is the current President of the Canadian Hematological Society and Chairman of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia (CCGM-CML). He has served on numerous basic and clinical research panels including the Medical Research Council of Canada, the Leukemia Research Fund of Canada, the National Cancer Institute of Canada Clinical Trials Hematology Executive, and the Canadian Blood and Marrow Transplant Group.

He has held a number of research grants supported by the MRC, LRFC, CRSI, MSSC, and is actively engaged in clinical trials for hematological malignancies and stem cell transplantation. Dr. Laneuville serves on the Honorary Medical Board of the Leukemia Research Fund of Canada, and is a member of various Ministerial Advisory Committees related to blood transfusion and transfusion safety.

source: canadianhematologysociety.org/exec_Laneuville.htm

Video by: Miguel Legault